Ann Dermatol.  2018 Aug;30(4):489-490. 10.5021/ad.2018.30.4.489.

Pediatric Follicular Lymphoma: A Rare Variant

• Lee HJ
• Bang CH
• Lee JH
• Park YM
• Lee JY

• KMID: 2457534
• DOI: http://doi.org/10.5021/ad.2018.30.4.489

Abstract

No abstract available.

MeSH Terms

Lymphoma, Follicular*

Figure

• 

  Fig. 1 (A) A 3×3 cm-sized, skin-colored subcutaneous mass. (B) An amorphous material at the subcutaneous level. (C) An excised tissue showed an effacement of nodal architecture (H&E, ×100). (D) Cytologically atypical, but relatively monomorphic lymphocytes in the neoplastic follicles (H&E, ×400). Immunohistochemically, (E) the atypical lymphoid cells expressed CD10 (×100) and (F) bcl-6 (×100), (G) while bcl-2 (×100) were not found. (H) The proliferation index seen on Ki-67 staining was ranging from 80% to 90% (×100).

Reference

1. Agrawal R, Wang J. Pediatric follicular lymphoma: a rare clinicopathologic entity. Arch Pathol Lab Med. 2009; 133:142–146.

2. Louissaint A Jr, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, et al. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood. 2016; 128:1093–1100.

3. Yang SF, Chuang WY, Chang ST, Liu H, Chen RL, Chuang SS. Pediatric follicular lymphoma: a report of the first 3 cases from Taiwan and literature review. Pediatr Hematol Oncol. 2011; 28:661–668.

4. Kumar R, Galardy PJ, Dogan A, Rodriguez V, Khan SP. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma. Pediatr Blood Cancer. 2011; 57:317–320.